Live
PolicyFDA releases draft guidance on alternatives to animal testingAINVIDIA and Lilly announce $1B AI co-innovation labScienceMedVersa AI model matches specialists across imaging tasksLillyLilly launches Employer Connect to expand obesity care accessAccessCMS rule phases out fax machines, expected to save $782M yearlyScienceMerck to acquire Terns Pharma for $6.7B in leukemia betAIOpenAI introduces GPT-5.4 with frontier coding capabilitiesLillyZepbound KwikPen now available at self-pay pricing nationwidePolicyMedicare Part D out-of-pocket costs capped at $2,100 in 2026AccessAlzheimer's Assoc. leads shift to early detection and preventionAI57% of pharma now using AI to drive drug discoveryScienceGenerative AI poised to restore physician-patient bondLillyRetatrutide Phase 3: significant A1C and weight reductionsPolicyWhite House approves NIH's $48.7B FY2026 spending planAccessRural patients drive 50+ miles one-way for neurology accessAIOpenAI acquires Promptfoo for AI evaluation and testingScienceNIH: AI-powered tool could streamline chronic disease diagnosesLillyLilly projects $80–83B revenue for 2026 on GLP-1 momentumAccessCMS extends GENEROUS Model to lower Medicaid drug costsPolicyFDA streamlines biosimilar development, could save $20M per drugAIRoche deploys 3,500+ NVIDIA GPUs for drug discovery AI factoryScienceServier to buy Day One, pediatric cancer drugmaker, for $2.5BLillyLilly CMO: GLP-1 success brings societal obligation to do moreAccessSenate reintroduces AADAPT Act to strengthen dementia workforcePolicyFTC launches Healthcare Task Force to protect patientsScienceNEJM Catalyst: AI in healthcare moves from promise to practiceAIGTC 2026: agentic AI hits inflection point in life sciencesLillyLilly warns of safety risks in compounded tirzepatide with B12AccessPart the Cloud grants $11M for innovative Alzheimer's treatmentsPolicyFDA novel drug approvals tracker updated for 2026SciencePfizer Lyme vaccine cuts cases 73% but misses primary endpointAIChatGPT powers product discovery with agentic commerceAccessMedicare Part B premium rises to $202.90 for 2026LillyLilly launches Employer Connect to expand obesity care accessScienceNIH launches program to develop sophisticated disease modelsPolicyTrump secures $50B in funding for rural hospitalsAccessFY2026: $100M increase secured for dementia research fundingAINVIDIA expands open models for healthcare AIScienceOsimertinib combo extends lung cancer survival to 47 monthsPolicyFDA outlines proposed device guidance priorities for FY2026Access1yr+ average wait to see a dementia specialist in the USLillyRetatrutide Phase 3: significant A1C and weight reductionsScienceNovo Nordisk gains shot at better oral obesity drugs via VivtexPolicyNew FDA guidance could elevate the biosimilar marketAccessNew white paper: helping health systems build dementia care programsScienceNIH study: new opioid treatment outperforms standard of careScienceFDA unifies fragmented safety surveillance into single dashboardScience5 FDA approval decisions to watch in Q1 2026PolicyFDA releases draft guidance on alternatives to animal testingAINVIDIA and Lilly announce $1B AI co-innovation labScienceMedVersa AI model matches specialists across imaging tasksLillyLilly launches Employer Connect to expand obesity care accessAccessCMS rule phases out fax machines, expected to save $782M yearlyScienceMerck to acquire Terns Pharma for $6.7B in leukemia betAIOpenAI introduces GPT-5.4 with frontier coding capabilitiesLillyZepbound KwikPen now available at self-pay pricing nationwidePolicyMedicare Part D out-of-pocket costs capped at $2,100 in 2026AccessAlzheimer's Assoc. leads shift to early detection and preventionAI57% of pharma now using AI to drive drug discoveryScienceGenerative AI poised to restore physician-patient bondLillyRetatrutide Phase 3: significant A1C and weight reductionsPolicyWhite House approves NIH's $48.7B FY2026 spending planAccessRural patients drive 50+ miles one-way for neurology accessAIOpenAI acquires Promptfoo for AI evaluation and testingScienceNIH: AI-powered tool could streamline chronic disease diagnosesLillyLilly projects $80–83B revenue for 2026 on GLP-1 momentumAccessCMS extends GENEROUS Model to lower Medicaid drug costsPolicyFDA streamlines biosimilar development, could save $20M per drugAIRoche deploys 3,500+ NVIDIA GPUs for drug discovery AI factoryScienceServier to buy Day One, pediatric cancer drugmaker, for $2.5BLillyLilly CMO: GLP-1 success brings societal obligation to do moreAccessSenate reintroduces AADAPT Act to strengthen dementia workforcePolicyFTC launches Healthcare Task Force to protect patientsScienceNEJM Catalyst: AI in healthcare moves from promise to practiceAIGTC 2026: agentic AI hits inflection point in life sciencesLillyLilly warns of safety risks in compounded tirzepatide with B12AccessPart the Cloud grants $11M for innovative Alzheimer's treatmentsPolicyFDA novel drug approvals tracker updated for 2026SciencePfizer Lyme vaccine cuts cases 73% but misses primary endpointAIChatGPT powers product discovery with agentic commerceAccessMedicare Part B premium rises to $202.90 for 2026LillyLilly launches Employer Connect to expand obesity care accessScienceNIH launches program to develop sophisticated disease modelsPolicyTrump secures $50B in funding for rural hospitalsAccessFY2026: $100M increase secured for dementia research fundingAINVIDIA expands open models for healthcare AIScienceOsimertinib combo extends lung cancer survival to 47 monthsPolicyFDA outlines proposed device guidance priorities for FY2026Access1yr+ average wait to see a dementia specialist in the USLillyRetatrutide Phase 3: significant A1C and weight reductionsScienceNovo Nordisk gains shot at better oral obesity drugs via VivtexPolicyNew FDA guidance could elevate the biosimilar marketAccessNew white paper: helping health systems build dementia care programsScienceNIH study: new opioid treatment outperforms standard of careScienceFDA unifies fragmented safety surveillance into single dashboardScience5 FDA approval decisions to watch in Q1 2026

Extraordinary medicine

deserves an experience engineered with the same precision.

A design perspective,
prepared for the Lilly Incubation Lab